Calciphylaxis in end-stage renal disease patients

Nephrology Dialysis Transplantation

Volumn 27, Issue 9, 2012, Pages 3663-

  Verdalles, Ursula ^a   García De Vinuesa, Soledad ^a   Luño, José ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCIUM; PARATHYROID HORMONE; PHOSPHATE; WARFARIN;

ALBUMIN BLOOD LEVEL; CALCINOSIS; CALCIUM BLOOD LEVEL; CARDIOMETABOLIC SYNDROME; HEALTH SURVEY; HEMODIALYSIS; HUMAN; HYPOTENSION; KIDNEY FAILURE; LETTER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RISK FACTOR; SKIN BIOPSY; SUBCUTANEOUS FAT;

ANTICOAGULANTS; CALCIPHYLAXIS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS; SERUM ALBUMIN; WARFARIN;

EID: 84865743708     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs271     Document Type: Letter

References (4)

1. Hayashi M, Takamatsu I, Kanno Y et al. for the Japanese Calciphylaxis Study Group. A case-control study of calciphylaxis in Japanese end-stage renal disease patients. Nephrol Dial Transplant 2012; 27: 1580-1584.
2. Verdalles U, Cueva Pde L, Verde E et al. Calciphylaxis: a severe complication of the cardiometabolic syndrome in patients receiving hemodialysis. J Cardiometab Syndr 2008; 3: 63-67.
3. Bleyer AJ, Choi M, Igwemezie B et al. A case control study of proximal calciphylaxis. Am J Kidney Dis 1998; 32: 376-383.
4. Weenig RH, Sewell LD, Davis MD et al. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 2007; 56: 569-579.